Meet with BIOVECTRA at TIDES 2023!
San Diego, California | May 7-10, 2023
Schedule a meeting with us at this year's TIDES event and discover how BIOVECTRA can help with your mRNA, pDNA, and lipid nanoparticle (LNP) product manufacturing needs.
Our state-of-the-art process development and analytical testing laboratories cover everything from cell line development to GMP production and sterile products.
BIOVECTRA's new state-of-the-art Biomanufacturing and Vaccine Center, opening in 2023, has the capability to develop and manufacture plasmid DNA and mRNA for use in:
- Viral Vector Production
- Gene Editing Applications
- Autologous and Allogenic Cell Therapies
At BIOVECTRA we specialize in clinical-to-commercial scale production capabilities for:
- Synthetic small molecules
- Highly potent APIs
Schedule a meeting with us and discover how we can support your mRNA, pDNA, and LNP projects and solve your most complex challenges.